Molecule triggers reaction in crucial enzyme allows cancer-infected cells to become more receptive to accepting treatment & enhances the effectiveness of cancer-treating drugs.
Hebrew University researchers have pinpointed the process by which tumors become resistant to cancer treatments, according to NoCamels, paving the way for significant changes in cancer-treating drugs.
While Israel has developed several anti-cancer drugs, not every patient will benefit from every drug; the correct cancer treatment for any given person must be individualized. Research has thus focused heavily on determining why certain tumors reject specific treatments – and how to universalize anti-cancer drugs to become more and more accessible. Continue Reading »